BACKGROUND: Efforts to identify hospital-acquired complications from claims data by applying exclusion rules to discharge diagnosis codes exhibit low positive predictive value (PPV). The PPV improves when a variable is added to each secondary diagnosis to indicate whether the condition was "present-on-admission" (POA) or "hospital-acquired". Such indicator variables will soon be required for Medicare reimbursement. No estimates are available, however, of the proportion of hospital-acquired complications that are missed (sensitivity) using either exclusion rules or indicator variables. We estimated sensitivity, specificity, PPV, and negative predictive value (NPV) of claims-based approaches using the Rochester Epidemiology Project (REP) venous thromboembolism (VTE) cohort as a "gold standard." METHODS: All inpatient encounters by Olmsted County, Minnesota, residents at Mayo Clinic-affiliated hospitals 1995-1998 constituted the at-risk-population. REP-identified hospital-acquired VTE consisted of all objectively-diagnosed VTE among County residents 1995-1998, whose onset of symptoms occurred during inpatient stays at these hospitals, as confirmed by detailed review of County residents' provider-linked medical records. Claims-based approaches used billing data from these hospitals. RESULTS: Of 37,845 inpatient encounters, 98 had REP-identified hospital-acquired VTE; 47 (48%) were medical encounters. NPV and specificity were >99% for both claims-based approaches. Although indicator variables provided higher PPV (74%) compared with exclusion rules (35%), the sensitivity for exclusion rules was 74% compared with only 38% for indicator variables. Misclassification was greater for medical than surgical encounters. CONCLUSIONS: Utility and accuracy of claims data for identifying hospital-acquired conditions, including POA indicator variables, requires close attention be paid by clinicians and coders to what is being recorded.
BACKGROUND: Efforts to identify hospital-acquired complications from claims data by applying exclusion rules to discharge diagnosis codes exhibit low positive predictive value (PPV). The PPV improves when a variable is added to each secondary diagnosis to indicate whether the condition was "present-on-admission" (POA) or "hospital-acquired". Such indicator variables will soon be required for Medicare reimbursement. No estimates are available, however, of the proportion of hospital-acquired complications that are missed (sensitivity) using either exclusion rules or indicator variables. We estimated sensitivity, specificity, PPV, and negative predictive value (NPV) of claims-based approaches using the Rochester Epidemiology Project (REP) venous thromboembolism (VTE) cohort as a "gold standard." METHODS: All inpatient encounters by Olmsted County, Minnesota, residents at Mayo Clinic-affiliated hospitals 1995-1998 constituted the at-risk-population. REP-identified hospital-acquired VTE consisted of all objectively-diagnosed VTE among County residents 1995-1998, whose onset of symptoms occurred during inpatient stays at these hospitals, as confirmed by detailed review of County residents' provider-linked medical records. Claims-based approaches used billing data from these hospitals. RESULTS: Of 37,845 inpatient encounters, 98 had REP-identified hospital-acquired VTE; 47 (48%) were medical encounters. NPV and specificity were >99% for both claims-based approaches. Although indicator variables provided higher PPV (74%) compared with exclusion rules (35%), the sensitivity for exclusion rules was 74% compared with only 38% for indicator variables. Misclassification was greater for medical than surgical encounters. CONCLUSIONS: Utility and accuracy of claims data for identifying hospital-acquired conditions, including POA indicator variables, requires close attention be paid by clinicians and coders to what is being recorded.
Authors: Gavin Wardle; Walter P Wodchis; Audrey Laporte; Geoffrey M Anderson; G Ross Baker Journal: Health Serv Res Date: 2011-10-27 Impact factor: 3.402
Authors: Cynthia L Leibson; Allen W Brown; Jeanine E Ransom; Nancy N Diehl; Patricia K Perkins; Jay Mandrekar; James F Malec Journal: Epidemiology Date: 2011-11 Impact factor: 4.822
Authors: Courtney R Murphy; Lyndsey O Hudson; Brian G Spratt; Kristen Elkins; Leah Terpstra; Adrijana Gombosev; Christopher Nguyen; Paul Hannah; Richard Alexander; Mark C Enright; Susan S Huang Journal: Infect Control Hosp Epidemiol Date: 2013-04-22 Impact factor: 3.254
Authors: Kevin P Cohoon; Cynthia L Leibson; Jeanine E Ransom; Aneel A Ashrani; Myung S Park; Tanya M Petterson; Kirsten Hall Long; Kent R Bailey; John A Heit Journal: Surgery Date: 2015-01-26 Impact factor: 3.982
Authors: Jennifer L St Sauver; David O Warner; Barbara P Yawn; Debra J Jacobson; Michaela E McGree; Joshua J Pankratz; L Joseph Melton; Véronique L Roger; Jon O Ebbert; Walter A Rocca Journal: Mayo Clin Proc Date: 2013-01 Impact factor: 7.616
Authors: John A Heit; Aneel Ashrani; Daniel J Crusan; Robert D McBane; Tanya M Petterson; Kent R Bailey Journal: Thromb Haemost Date: 2016-12-15 Impact factor: 5.249
Authors: Kevin P Cohoon; Jeanine E Ransom; Cynthia L Leibson; Aneel A Ashrani; Tanya M Petterson; Kirsten Hall Long; Kent R Bailey; John A Heit Journal: Am J Med Date: 2016-03-21 Impact factor: 4.965